Twenty-five laboratory study to illustrate the capabilities of top-down mass spectrometry in detailing monoclonal antibody structure and modifications
CAMBRIDGE, MA–(Marketwired – February 28, 2017) – The Consortium for Top Down Proteomics today announced the launch of their inter-laboratory study for characterizing monoclonal antibodies (mAbs) by top-down mass spectrometry techniques. With the continuing growth in the development and adoption of mAbs for a wide range of therapeutic uses, there is increasing demand for higher quality characterization of these complex species.
https://www.topdownproteomics.org/wp-content/uploads/2018/08/CTDP-logo1-w-tagline-300x152.jpg00Paul Danishttps://www.topdownproteomics.org/wp-content/uploads/2018/08/CTDP-logo1-w-tagline-300x152.jpgPaul Danis2017-02-28 00:00:052018-02-09 21:55:37Consortium for Top-Down Proteomics Launches Pilot Project for Characterization of Monoclonal Antibodies
Consortium for Top-Down Proteomics Launches Pilot Project for Characterization of Monoclonal Antibodies
Twenty-five laboratory study to illustrate the capabilities of top-down mass spectrometry in detailing monoclonal antibody structure and modifications
CAMBRIDGE, MA–(Marketwired – February 28, 2017) – The Consortium for Top Down Proteomics today announced the launch of their inter-laboratory study for characterizing monoclonal antibodies (mAbs) by top-down mass spectrometry techniques. With the continuing growth in the development and adoption of mAbs for a wide range of therapeutic uses, there is increasing demand for higher quality characterization of these complex species.
Read more